Clinical Trial Update: A Study of LY4257496 in Participants With Cancer (OMNIRAY) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for LY4257496 in cancer patients; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Cancer
• Colorectal Cancer
• Endometrial Cancer
• Prostate Cancer

Drugs mentioned

• LY4257496

Snippet

Sponsor: Eli Lilly and Company | Conditions: Breast Neoplasms, Colorectal Neoplasms | Phase 1 | Status: RECRUITING